![](https://www.pymnts.com/wp-content/uploads/2021/03/shutterstock_1684279723-e1603704315730.jpg)
The European Commission has approved a SEK 164 million (US$19.38 million) Swedish scheme to support air traffic control services affected by the coronavirus outbreak. The scheme was approved under the State aid Temporary Framework.
In the context of the coronavirus outbreak, Sweden introduced restrictions to avoid the spread of the virus, which has caused dramatic drops in air travel. Specifically in 2020, the number of air passengers in Sweden was 75% lower than in 2019. The aim of the scheme is to cover the losses for the years 2020 and 2021 incurred by small and medium sized companies active in air traffic management, which have suffered significant losses in revenues due to these drops in the number of flights performed.
Under the scheme, the public support will take the form of loans provided by the Swedish National Transport Administration (Trafikverket) with subsidized interest rates. The Commission found that the Swedish scheme is in line with the conditions set out in the Temporary Framework.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan